Twin Tree Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-28,200
Closed -$2.96M 1296
2022
Q2
$2.96M Sell
28,200
-37,600
-57% -$4.8M ﹤0.01% 998
2022
Q1
$11.3M Buy
65,800
+50,200
+322% +$7.5M 0.02% 668
2021
Q4
$2.52M Buy
+15,600
New +$2.51M 0.01% 1043
2021
Q2
Sell
-200
Closed -$53K 1307
2021
Q1
$53K Sell
200
-29,000
-99% -$8.18M ﹤0.01% 1206
2020
Q4
$8.56M Buy
+29,200
New +$7.49M 0.03% 481

Other funds holding AMED

Twin Tree Management's AMED Position: Q3 2022 in Review

Twin Tree Management sold out of Amedisys (AMED) in Q3 2022, closing a stake of 106,236 shares — an estimated $11.2M sold.

Twin Tree Management first reported a position in AMED in Q2 2020 and held it in 3 quarters. The position peaked at $11.2M in Q2 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Twin Tree Management reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Twin Tree Management sold 106,236 Amedisys shares in Q3 2022, an estimated $11.2M.
  • Twin Tree Management first reported a position in Amedisys in Q2 2020 and held it in 3 quarters.
  • Twin Tree Management's Amedisys position peaked at $11.2M in Q2 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Twin Tree Management's 13F filing for Q3 2022, filed 10 Nov 2022.